Topic: AS06-Prognosis/AS06b-Predictive factors of response to treatment: AUGMENTED ACTIVITY OF THE ALVOCIDIB AND 5-AZACYTIDINE COMBINATION IN MYELODYSPLASTIC NEOPLASMS IS ASSOCIATED WITH THE PRESENCE OF ASXL1 MUTATIONS

Autor:	V. Ryabov, Q. Xu, N. Schmitt, A. Streuer, G. Ge, L. Bolanos, M. Wunderlich, J.-C. Jann, A. Wein, E. Altrock, S. Mukherjee, A.M. Ali, F. Rapp, V. Nowak, N. Weimer, J. Obländer, I. Palme, M. Göl, A. Jawhar, A. Darwich, P. Wuchter, C. Weiss, A. Raza, J.M. Foulks, D.T. Starczynowski, F.-C. Yang, G. Metzgeroth, L. Steiner, M. Jawhar, W.-K. Hofmann, D. Nowak
Rok vydání:	2023
Předmět:	Cancer Research Oncology Hematology
Zdroj:	Leukemia Research. 128:107238
ISSN:	0145-2126
DOI:	10.1016/j.leukres.2023.107238
Databáze:	OpenAIRE
Externí odkaz:	https://explore.openaire.eu/search/publication?articleId=doi_________::863893787c5f27b95ce96a211da4ecf5 https://doi.org/10.1016/j.leukres.2023.107238 Zobrazit plný text záznamu Full Text from ScienceDirect